Exploring the mechanism of IL-33-mediated activation of the Wnt/β-catenin signaling pathway through Ror2 in intrauterine adhesions
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Fengjuan Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical, School of Ningxia Medical University, Yinchuan, China; Department of Beijing National Biochip, Research Center Sub-Center…. Hauptthemen laut MEDLINE: Interleukin-33, Receptor Tyrosine Kinase-like Orphan Receptors, Wnt Signaling Pathway. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Ningxia Hui Autonomous Region Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Intrauterine adhesions (IUA) are a major cause of secondary infertility, yet existing treatments have limited efficacy. This study explores the potential of targeting Ror2, a key mediator in the IL-33/Wnt/β-catenin signaling pathway for IUA treatment. METHODS: First, we established an IL-33-induced intrauterine adhesion (IUA) mouse endometrial organoid (EMOs) model. Using parallel reaction monitoring (PRM) technology, we identified Ror2 as the target protein linking IL-33 to the Wnt/β-catenin signaling pathway in mouse uterine tissue. Subsequently, we constructed lentiviral vectors for Ror2 knockdown (Lv-shRor2) and overexpression (Lv-Ror2) to evaluate the role of Ror2 in endometrial fibrosis and stem cell proliferation. Finally, we assessed murine fertility via in situ injection of Ror2-overexpressing adenoviral particles (Ad-Ror2) into the uterine cavity. RESULTS: The results showed that IL-33 at 100 ng/ml for 24 h had the strongest effect on the model. Lv-shRor2 promoted endometrial fibrosis by activating the Wnt/β-catenin pathway, while Lv-Ror2 inhibited this pathway, enhancing endometrial stem cell proliferation and improving fertility in IUA mice. CONCLUSIONS: These findings suggest that Ror2 could be a promising target for regulating the Wnt/β-catenin pathway in IUA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical, School of Ningxia Medical University, Yinchuan, China; Department of Beijing National Biochip, Research Center Sub-Center in Ningxia, Yinchuan, China; Ningxia Key Laboratory of Stem Cell and…
- Department of Beijing National Biochip, Research Center Sub-Center in Ningxia, Yinchuan, China; Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, China.
- Department of Gynecology, General Hospital of Ningxia Medical University, Yinchuan, China.
- The First Clinical Medical, School of Ningxia Medical University, Yinchuan, China.
- Department of Beijing National Biochip, Research Center Sub-Center in Ningxia, Yinchuan, China; Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, China; Department of Gynecology, G…
Förderung
- National Natural Science Foundation of China
- Ningxia Hui Autonomous Region Natural Science Foundation
Zitieren
APA
Xu, F., Luo, S., Ma, Y., Jin, Y., Zou, X., & Liu, D. (2025). Exploring the mechanism of IL-33-mediated activation of the Wnt/β-catenin signaling pathway through Ror2 in intrauterine adhesions. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112000
Vancouver
Xu F, Luo S, Ma Y, Jin Y, Zou X, Liu D. Exploring the mechanism of IL-33-mediated activation of the Wnt/β-catenin signaling pathway through Ror2 in intrauterine adhesions. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112000
BibTeX
@article{Xu2025,
author = {Xu, Fengjuan and Luo, Sang and Ma, Yulan and Jin, Yiran and Zou, Xiaojie and Liu, Dan},
title = {Exploring the mechanism of IL-33-mediated activation of the Wnt/β-catenin signaling pathway through Ror2 in intrauterine adhesions},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112000}
}
EUVIMED